Zobrazeno 1 - 10
of 1 174
pro vyhledávání: '"Folate-receptor 1"'
Autor:
Rushton T; Johns Hopkins University, Baltimore, MD, United States of America. Electronic address: trushto1@jh.edu., Krause HB; Caris Life Sciences, United States of America., Samec T; Caris Life Sciences, United States of America., Elliott A; Caris Life Sciences, United States of America., Karnezis AN; University of California-Davis Health, Sacramento, CA, United States of America., Toboni MD; University of Alabama at Birmingham, Birmingham, AL, United States of America., Thaker PH; Washington University in St. Lous, St. Louis, MO, United States of America., Braxton DR; Hoag Family Cancer Institute and Hoag Health, Newport Beach, CA, United States of America., Oberley M; Caris Life Sciences, United States of America., Gershenson DM; University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Armstrong DK; Johns Hopkins University, Baltimore, MD, United States of America.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2024 Dec; Vol. 191, pp. 80-85. Date of Electronic Publication: 2024 Oct 03.
Autor:
Miyazawa Y; Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo 060-0812, Japan., Furugen A; Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo 060-0812, Japan. Electronic address: afurugen@keio.jp., Aoyagi R; Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo 060-0812, Japan., Kosugi H; Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo 060-0812, Japan., Nishimura A; Department of Pharmacy, Hokkaido University Hospital, Kita-14-jo, Nishi-5-chome, Kita-ku, Sapporo 060-8648, Japan., Umazume T; Department of Obstetrics, Hokkaido University Hospital, Kita-14-jo, Nishi-5-chome, Kita-ku, Sapporo 060-8648, Japan., Narumi K; Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo 060-0812, Japan., Kobayashi M; Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12-jo, Nishi-6-chome, Kita-ku, Sapporo 060-0812, Japan. Electronic address: masaki@pharm.hokudai.ac.jp.
Publikováno v:
Toxicology in vitro : an international journal published in association with BIBRA [Toxicol In Vitro] 2024 Dec; Vol. 101, pp. 105934. Date of Electronic Publication: 2024 Sep 03.
Autor:
Bethke M; Miltenyi Biotec B.V. & Co. KG, 51429 Bergisch Gladbach, Germany., Abramowski P; Miltenyi Biotec B.V. & Co. KG, 51429 Bergisch Gladbach, Germany., Droste M; Miltenyi Biotec B.V. & Co. KG, 51429 Bergisch Gladbach, Germany., Felsberger A; Miltenyi Biotec B.V. & Co. KG, 51429 Bergisch Gladbach, Germany., Kochsiek L; Miltenyi Biotec B.V. & Co. KG, 51429 Bergisch Gladbach, Germany., Kotter B; Miltenyi Biotec B.V. & Co. KG, 51429 Bergisch Gladbach, Germany., Plettig L; Miltenyi Biotec B.V. & Co. KG, 51429 Bergisch Gladbach, Germany., Antonova K; Miltenyi Biotec B.V. & Co. KG, 51429 Bergisch Gladbach, Germany., Baghdo S; Miltenyi Biotec B.V. & Co. KG, 51429 Bergisch Gladbach, Germany., Burzan N; Miltenyi Biotec B.V. & Co. KG, 51429 Bergisch Gladbach, Germany., Tomszak F; Miltenyi Biotec B.V. & Co. KG, 51429 Bergisch Gladbach, Germany., Martinez-Osuna M; Miltenyi Biotec B.V. & Co. KG, 51429 Bergisch Gladbach, Germany., Eckardt D; Miltenyi Biotec B.V. & Co. KG, 51429 Bergisch Gladbach, Germany., Herbel C; Miltenyi Biotec B.V. & Co. KG, 51429 Bergisch Gladbach, Germany.
Publikováno v:
Cells [Cells] 2024 Nov 14; Vol. 13 (22). Date of Electronic Publication: 2024 Nov 14.
Autor:
Kfoury M; Medical Oncology Department, Institut Paoli-Calmettes, 13009 Marseille, France., Finetti P; Predictive Oncology Laboratory, Inserm UMR1068, Centre National de la Recherche Scientifique (CNRS) UMR7258, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, Aix-Marseille University U105, 13009 Marseille, France., Mamessier E; Predictive Oncology Laboratory, Inserm UMR1068, Centre National de la Recherche Scientifique (CNRS) UMR7258, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, Aix-Marseille University U105, 13009 Marseille, France., Bertucci F; Medical Oncology Department, Institut Paoli-Calmettes, 13009 Marseille, France.; Predictive Oncology Laboratory, Inserm UMR1068, Centre National de la Recherche Scientifique (CNRS) UMR7258, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, Aix-Marseille University U105, 13009 Marseille, France., Sabatier R; Medical Oncology Department, Institut Paoli-Calmettes, 13009 Marseille, France.; Predictive Oncology Laboratory, Inserm UMR1068, Centre National de la Recherche Scientifique (CNRS) UMR7258, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, Aix-Marseille University U105, 13009 Marseille, France.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Nov 07; Vol. 25 (22). Date of Electronic Publication: 2024 Nov 07.
Autor:
Bukowski K; Department of Medical Biophysics, Institute of Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, 141/143 Pomorska Street, 90-236 Lodz, Poland., Rogalska A; Department of Medical Biophysics, Institute of Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, 141/143 Pomorska Street, 90-236 Lodz, Poland., Marczak A; Department of Medical Biophysics, Institute of Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, 141/143 Pomorska Street, 90-236 Lodz, Poland.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Nov 06; Vol. 25 (22). Date of Electronic Publication: 2024 Nov 06.
Autor:
Kim ET; Department of Obstetrics and Gynecology, Kosin University College of Medicine, Pusan, Republic of Korea., Kim JH; Center for Gynecologic Cancer, National Cancer Center, Goyang, Republic of Korea., Park EY; Biostatistics Collaboration Team, Research Core Center, National Cancer Center, Goyang, Republic of Korea., Song IH; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea., Park HS; Department of Obstetrics and Gynecology, Kosin University College of Medicine, Pusan, Republic of Korea., Park SY; Center for Gynecologic Cancer, National Cancer Center, Goyang, Republic of Korea., Lim MC; Center for Gynecologic Cancer, National Cancer Center, Goyang, Republic of Korea.; Cancer Control and Policy, National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Republic of Korea.; Rare & Paediatric Cancer Branch and Immuno-Oncology Branch, Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang, Republic of Korea.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Nov; Vol. 13 (21), pp. e70392.
Autor:
James RL; From the Departments of Assay Development (James, Sisserson), Clinical Development & Medical Affairs (Cai, Dumas, Inge, Ranger-Moore, Mason), and Oncology (McArthur), Personalized Healthcare Solutions, Roche Tissue Diagnostics, Tucson, Arizona., Sisserson T; From the Departments of Assay Development (James, Sisserson), Clinical Development & Medical Affairs (Cai, Dumas, Inge, Ranger-Moore, Mason), and Oncology (McArthur), Personalized Healthcare Solutions, Roche Tissue Diagnostics, Tucson, Arizona., Cai Z; From the Departments of Assay Development (James, Sisserson), Clinical Development & Medical Affairs (Cai, Dumas, Inge, Ranger-Moore, Mason), and Oncology (McArthur), Personalized Healthcare Solutions, Roche Tissue Diagnostics, Tucson, Arizona., Dumas ME; From the Departments of Assay Development (James, Sisserson), Clinical Development & Medical Affairs (Cai, Dumas, Inge, Ranger-Moore, Mason), and Oncology (McArthur), Personalized Healthcare Solutions, Roche Tissue Diagnostics, Tucson, Arizona., Inge LJ; From the Departments of Assay Development (James, Sisserson), Clinical Development & Medical Affairs (Cai, Dumas, Inge, Ranger-Moore, Mason), and Oncology (McArthur), Personalized Healthcare Solutions, Roche Tissue Diagnostics, Tucson, Arizona., Ranger-Moore J; From the Departments of Assay Development (James, Sisserson), Clinical Development & Medical Affairs (Cai, Dumas, Inge, Ranger-Moore, Mason), and Oncology (McArthur), Personalized Healthcare Solutions, Roche Tissue Diagnostics, Tucson, Arizona., Mason A; From the Departments of Assay Development (James, Sisserson), Clinical Development & Medical Affairs (Cai, Dumas, Inge, Ranger-Moore, Mason), and Oncology (McArthur), Personalized Healthcare Solutions, Roche Tissue Diagnostics, Tucson, Arizona., Sloss CM; the Department of Translational Sciences, ImmunoGen Inc, Waltham, Massachusetts (Sloss)., McArthur K; From the Departments of Assay Development (James, Sisserson), Clinical Development & Medical Affairs (Cai, Dumas, Inge, Ranger-Moore, Mason), and Oncology (McArthur), Personalized Healthcare Solutions, Roche Tissue Diagnostics, Tucson, Arizona.
Publikováno v:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 Nov 01; Vol. 148 (11), pp. 1226-1233.
Autor:
Tu YP; Clinical Pharmacology, ImmunoGen, Waltham, MA, USA., Lagraauw HM; qPharmetra LLC, Nijmegen, The Netherlands., Method M; Clinical Development, ImmunoGen, Waltham, MA, USA., Wang Y; Biostatistics, ImmunoGen, Waltham, MA, USA., Hanze E; qPharmetra LLC, Nijmegen, The Netherlands., Li L; Biostatistics, ImmunoGen, Waltham, MA, USA., Parrott T; Pharmacovigilance, ImmunoGen, Waltham, MA, USA., Sloss CM; Translational Science, ImmunoGen, Waltham, MA, USA., Westin EH; Clinical Development, ImmunoGen, Waltham, MA, USA.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2025 Jan; Vol. 91 (1), pp. 220-231. Date of Electronic Publication: 2024 Sep 22.
Autor:
Dewulf J; Precirix, Burg. Etienne Demunterlaan 3, Brussels, Matthias, B-1090, Belgium., Massa S; Precirix, Burg. Etienne Demunterlaan 3, Brussels, Matthias, B-1090, Belgium., Navarro L; Precirix, Burg. Etienne Demunterlaan 3, Brussels, Matthias, B-1090, Belgium., Dekempeneer Y; Precirix, Burg. Etienne Demunterlaan 3, Brussels, Matthias, B-1090, Belgium., Santens F; Precirix, Burg. Etienne Demunterlaan 3, Brussels, Matthias, B-1090, Belgium., Ceuppens H; Laboratory for Molecular and Cellular Therapy, Translational Oncology Research Centre, Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, 1090, Belgium., Breckpot K; Laboratory for Molecular and Cellular Therapy, Translational Oncology Research Centre, Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, 1090, Belgium., Van Ginderachter JA; Lab of Cellular and Molecular Immunology, Brussels Centre for Immunology, Vrije Universiteit Brussel, Brussels, 1050, Belgium.; Myeloid Cell Immunology Lab, VIB Centre for Inflammation Research, Brussels, 1050, Belgium., Lahoutte T; Precirix, Burg. Etienne Demunterlaan 3, Brussels, Matthias, B-1090, Belgium.; Molecular Imaging and Therapy Research Group, Vrije Universiteit Brussel, Brussels, 1090, Belgium., D'Huyvetter M; Precirix, Burg. Etienne Demunterlaan 3, Brussels, Matthias, B-1090, Belgium. matthias.dhuyvetter@precirix.com.; Molecular Imaging and Therapy Research Group, Vrije Universiteit Brussel, Brussels, 1090, Belgium. matthias.dhuyvetter@precirix.com., Devoogdt N; Precirix, Burg. Etienne Demunterlaan 3, Brussels, Matthias, B-1090, Belgium.; Molecular Imaging and Therapy Research Group, Vrije Universiteit Brussel, Brussels, 1090, Belgium.
Publikováno v:
Journal of nanobiotechnology [J Nanobiotechnology] 2024 Dec 19; Vol. 22 (1), pp. 763. Date of Electronic Publication: 2024 Dec 19.
Autor:
Moore KN; OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: kathleen-moore@ouhsc.edu., Lorusso D; Gynaecology Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS and Università Cattolica del Sacro Cuore, Rome, Italy., Oaknin A; Medical Oncology Service, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Oza A; Ontario Institute for Cancer Research, Toronto, Canada., Colombo N; Gynecologic Oncology Program, European Institute of Oncology IRCCS, Milan, Italy; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy., Van Gorp T; University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium., O'Malley DM; James Cancer Center/The Ohio State University, Columbus, OH, USA., Banerjee S; The Royal Marsden NHS Foundation Trust and Institute for Cancer Research, London, UK., Murphy CG; Cancer Centre and Cancer Trials, Bon Secours Hospital Cork, Cork, Ireland., Harter P; Kliniken Essen-Mitte, Essen, Germany., Konecny GE; UCLA Health, Los Angeles, CA, USA., Pautier P; Institut Gustave Roussy, Paris, France., Method M; ImmunoGen, Inc., Waltham, MA, USA., Wang Y; ImmunoGen, Inc., Waltham, MA, USA., Coleman RL; Texas Oncology, The Woodlands, TX, USA., Birrer M; Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Matulonis UA; Dana-Farber Cancer Institute, Boston, MA, USA.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2024 Dec; Vol. 191, pp. 249-258. Date of Electronic Publication: 2024 Oct 25.